A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration 

Description

Join our experts as they discuss practical aspects of integrating liver-directed therapy for the treatment of MASH. Listen as they discuss real-world successes and challenges with using THR-B agonists and GLP-1RAs. Catch up on the latest data on noninvasive testing and other treatments in late-stage development. 



Supported by: Madrigal Pharmaceuticals

Organized by: AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.